Literature DB >> 20809110

Association between cystatin C and inflammation in patients with essential hypertension.

Takafumi Okura1, Masanori Jotoku, Jun Irita, Daijiro Enomoto, Tomoaki Nagao, Veena Rasika Desilva, Shiho Yamane, Zuowei Pei, Shiho Kojima, Yasuyuki Hamano, Shinichi Mashiba, Mie Kurata, Ken-ichi Miyoshi, Jitsuo Higaki.   

Abstract

BACKGROUND: Serum cystatin C is not only a marker of renal function but also acts as an independent risk factor for cardiovascular damage, heart failure, and death. It is known that the initiation and progression of these cardiovascular events contributes to renal dysfunction and chronic inflammation. In this study, we investigated the relationship between cystatin C and proinflammatory cytokines.
METHODS: Eighty-eight patients with essential hypertension participated in the study, which involved measuring proinflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and C reactive protein (CRP).
RESULTS: Positive correlations were detected between cystatin C and estimated glomerular filtration rate (eGFR) (r = -0.503, p < 0.001), systolic blood pressure (r = -0.246, p = 0.034), and pulse pressure (r = -0.295, p = 0.010). In contrast, serum creatinine correlated only with eGFR (r = -0.755, p < 0.001) and eGFR correlated only with age (r = -0.339, p = 0.001) and not with the other clinical parameters, whereas cystatin C also correlated with log natural (ln) IL-6 (r = -0.247, p = 0.033) and ln TNF-α (r = -0.405, p < 0.001) but not with CRP (r = -0.188, p = 0.108). In contrast, plasma creatinine and eGFR did not correlate with any of these proinflammatory cytokines. Stepwise regression analysis showed that ln TNF-α, eGFR and pulse pressure were independent determinants of serum cystatin C concentration.
CONCLUSION: This study showed that cystatin C is a marker of inflammation as well as renal function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809110     DOI: 10.1007/s10157-010-0334-8

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  31 in total

1.  Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study.

Authors:  Ann M O'Hare; Anne B Newman; Ronit Katz; Linda F Fried; Catherine O Stehman-Breen; Stephen L Seliger; David S Siscovick; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

2.  Structure and expression of the human cystatin C gene.

Authors:  M Abrahamson; I Olafsson; A Palsdottir; M Ulvsbäck; A Lundwall; O Jensson; A Grubb
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

3.  Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study.

Authors:  David Singh; Mary A Whooley; Joachim H Ix; Sadia Ali; Michael G Shlipak
Journal:  Nephrol Dial Transplant       Date:  2007-01-08       Impact factor: 5.992

4.  Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension.

Authors:  Sanae Watanabe; Takafumi Okura; Mie Kurata; Jun Irita; Seiko Manabe; Ken-Ichi Miyoshi; Tomikazu Fukuoka; Akiko Gotoh; Kazuo Uchida; Jitsuo Higaki
Journal:  Clin Exp Hypertens       Date:  2006-07       Impact factor: 1.749

5.  Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate.

Authors:  J Kyhse-Andersen; C Schmidt; G Nordin; B Andersson; P Nilsson-Ehle; V Lindström; A Grubb
Journal:  Clin Chem       Date:  1994-10       Impact factor: 8.327

6.  Is C-reactive protein an independent risk factor for essential hypertension?

Authors:  L E Bautista; P López-Jaramillo; L M Vera; J P Casas; A P Otero; A I Guaracao
Journal:  J Hypertens       Date:  2001-05       Impact factor: 4.844

7.  Cystatin C measurement and its practical use in patients with various renal diseases.

Authors:  S Tian; E Kusano; T Ohara; K Tabei; Y Itoh; T Kawai; Y Asano
Journal:  Clin Nephrol       Date:  1997-08       Impact factor: 0.975

Review 8.  Novel clinical markers of vascular wall inflammation.

Authors:  G J Blake; P M Ridker
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

9.  C-reactive protein as an outcome predictor for maintenance hemodialysis patients.

Authors:  W F Owen; E G Lowrie
Journal:  Kidney Int       Date:  1998-08       Impact factor: 10.612

10.  Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate.

Authors:  A Grubb; O Simonsen; G Sturfelt; L Truedsson; H Thysell
Journal:  Acta Med Scand       Date:  1985
View more
  30 in total

1.  Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis.

Authors:  Min Ji Shin; Sang Heon Song; Ihm Soo Kwak; Soo Bong Lee; Dong Won Lee; Eun Young Seong; Il Young Kim; Harin Rhee; Naria Lee
Journal:  Clin Exp Nephrol       Date:  2012-01-26       Impact factor: 2.801

Review 2.  The internist and the renal resistive index: truths and doubts.

Authors:  Maria Boddi; Fabrizia Natucci; Elisa Ciani
Journal:  Intern Emerg Med       Date:  2015-09-04       Impact factor: 3.397

3.  Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.

Authors:  Jeffrey W Meeusen; Andrew D Rule; Nikolay Voskoboev; Nikola A Baumann; John C Lieske
Journal:  Clin Chem       Date:  2015-08-03       Impact factor: 8.327

4.  Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation.

Authors:  Anders Grubb; Jonas Björk; Ulf Nyman; Joanna Pollak; Johan Bengzon; Gustav Ostner; Veronica Lindström
Journal:  Scand J Clin Lab Invest       Date:  2011-01-04       Impact factor: 1.713

5.  Metabolic syndrome and renal injury.

Authors:  Yi-Jing Sheen; Wayne Huey-Herng Sheu
Journal:  Cardiol Res Pract       Date:  2011-03-13       Impact factor: 1.866

Review 6.  Current and novel renal biomarkers in heart failure.

Authors:  Kevin Damman; Adriaan A Voors; Gerjan Navis; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

7.  CamGFR v2: A New Model for Estimating the Glomerular Filtration Rate from Standardized or Non-standardized Creatinine in Patients with Cancer.

Authors:  Edward H Williams; Thomas R Flint; Claire M Connell; Daniel Giglio; Hassal Lee; Taehoon Ha; Eva Gablenz; Nicholas J Bird; James M J Weaver; Harry Potts; Cameron T Whitley; Michael A Bookman; Andy G Lynch; Hannah V Meyer; Simon Tavaré; Tobias Janowitz
Journal:  Clin Cancer Res       Date:  2020-12-10       Impact factor: 13.801

8.  Cystatin C and long term risk of community-acquired sepsis: a population-based cohort study.

Authors:  Thomas Clark Powell; John P Donnelly; Orlando M Gutiérrez; Russell L Griffin; Monika M Safford; Henry E Wang
Journal:  BMC Nephrol       Date:  2015-04-23       Impact factor: 2.388

9.  Anti-Inflammatory Effects and Prediction of Blood Pressure Response by Baseline Inflammatory State in Catheter-Based Renal Denervation.

Authors:  David Lang; Alexander Nahler; Thomas Lambert; Michael Grund; Jürgen Kammler; Jörg Kellermair; Hermann Blessberger; Alexander Kypta; Clemens Steinwender; Johann Auer
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-01       Impact factor: 3.738

10.  Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges.

Authors:  Hilde R H de Geus; Michiel G Betjes; Jan Bakker
Journal:  Clin Kidney J       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.